rifampin · Injection, Powder, Lyophilized, For Solution

What changed in the last 90 days

Every detected change for rifampin, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Rifamycin Antibacterial, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

• rifaximin· 19 makers

Common questions

Is Rifampin in shortage right now?

Yes. FDA currently lists Rifampin in shortage, with the reason given as "discontinuation of the manufacture of the drug". This page is rebuilt every morning from FDA's shortage database.

Who makes Rifampin?

22 companies have marketed Rifampin in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

What does Rifampin cost?

The typical pharmacy pays about $0.6802 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

Shortage reports for this molecule

• In shortage now — Rifadin, Injection, 600 mg (NDC 0068-0597-01)Feb 17, 2021
• Planned discontinuation — Rifadin, Injection, 600 mg/10 mL (NDC 0068-0597-01)Feb 17, 2021
• In shortage now — Rifampin, Injection, 600 mg (NDC 63323-351-20)Feb 17, 2021
• In shortage now — Rifampin, Injection, 600 mg (NDC 67457-445-60)Feb 17, 2021
• In shortage now — Rifampin, Injection, 600 mg/10 mL (NDC 67457-445-60)Feb 17, 2021